ULTRAGENYX PHARMACEUTICAL IN (RARE)
6 tracked managers currently hold RARE on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| TWO SIGMA INVESTMENTS, LP | Q3 2026 | TRIM | $47.1M | 0.0 % | 0.1 % | 3,130,527 | -490,673 |
| MILLENNIUM MANAGEMENT LLC | Q3 2026 | ADD | $22.8M | 0.0 % | 0.0 % | 1,518,082 | +757,257 |
| D. E. Shaw & Co., Inc. | Q3 2026 | TRIM | $13.4M | 0.0 % | 0.0 % | 892,102 | -838,091 |
| Point72 Asset Management, L.P. | Q3 2026 | NEW | $12.7M | 0.0 % | — | 844,410 | NEW |
| CITADEL ADVISORS LLC | Q3 2026 | ADD | $5.4M | 0.0 % | 0.0 % | 356,670 | +146,139 |
| Bridgewater Associates, LP | Q3 2026 | NEW | $857.5K | 0.0 % | — | 57,052 | NEW |